National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 3163 [2021-00653]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Immunology
(IMM), DPPS, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, RM 4205, Bethesda, MD 20892, (301)
594–0343, yanming@mail.nih.gov.
Name of Committee: National Institute of
Nursing Research Special Emphasis Panel;
Fellowship and Career Development.
Date: February 19, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ming Yan, MD, Ph.D.,
Scientific Review Officer, Immunology
(IMM), DPPS, Center for Scientific Review,
National Institute of Nursing Research,
National Institutes of Health, 6701 Rockledge
Drive, RM 4205 Bethesda, MD 20892, (301)
594–0343, yanming@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–00653 Filed 1–13–21; 8:45 am]
BILLING CODE 4140–01–P
Dated: January 8, 2021.
Tyeshia Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–00651 Filed 1–13–21; 8:45 am]
Prospective Grant of an Exclusive
Patent License: Development and
Commercialization of CD33-Specific
Chimeric Antigen Receptor (CAR)
Therapies for CD33-Expressing
Malignancies Using Natural Killer Cells
(NK Cells) Transduced With Retroviral
or Lentiviral Vectors
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lorna W. Role, Ph.D.,
Scientific Director, Division of Intramural
Research, National Institute of Neurological
Disorders and Stroke, 35A Convent Drive,
MSC 3716, Bethesda, MD 20892, lorna.role@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
AGENCY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF
NEUROLOGICAL DISORDERS AND
STROKE, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
SUMMARY:
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: April 11–13, 2021.
Time: 3:00 p.m. to 12:00 p.m.
VerDate Sep<11>2014
20:43 Jan 13, 2021
Jkt 253001
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
practice the inventions embodied in the
Patents and Patent Applications listed
in the Supplementary Information
section of this Notice to Senti Bio
(‘‘Senti’’), located in South San
Francisco, CA.
DATES: Only written comments and/or
applications for a license which are
received by the National Cancer
Institute’s Technology Transfer Center
on or before January 29, 2021 will be
considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
Exclusive Patent License should be
directed to: Jim Knabb, Senior
Technology Transfer Manager, NCI
Technology Transfer Center at Email:
jim.knabb@nih.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
3163
Intellectual Property
E–097–2018–0: Anti-CD33 Chimeric
Antigen Receptors for Treatment of
Human Acute Myeloid Leukemia
1. US Provisional Patent Application
62/643,015, filed March 14, 2018
(E–097–2018–0–US–01);
2. International Patent Application PCT/
US2019/022,309, filed March 14,
2019 (E–097–2018–0–PCT–02)
3. United Arab Emirates Application
No: P6001291/2020, filed
September 13, 2020 (E–097–2018–
0–AE–03)
4. Australia Application No:
2019235926, filed September 2,
2020 (E–097–2018–0–AU–04)
5. Canada Application No: 3,093,567,
filed September 9, 2020 (E–097–
2018–0–CA–05)
6. China Application No:
201980018105.0, filed September 9,
2020 (E–097–2018–0–CN–06)
7. Eurasia Application No: 202092044,
filed September 25, 2020 (E–097–
2018–0–EA–07)
8. European Patent Application No:
19714007.2, filed October 14, 2020
(E–097–2018–0–EP–08)
9. Israel Application No: 277078, filed
September 1, 2020 (E–097–2018–0–
IL–09)
10. India Application No:
202047039152, filed September 10,
2020 (E–097–2018–0–IN–10)
11. South Korea Application No: 2020–
7029302, filed October 13, 2020 (E–
097–2018–0–KR–11)
12. Mexico Application No: MX/a/2020/
009472, filed September 10, 2020
(E–097–2018–0–MX–12)
13. New Zealand Application No:
767782, filed September 13, 2020
(E–097–2018–0–NZ–13)
14. Saudi Arabia Application No:
520420134, filed September 13,
2020 (E–097–2018–0–SA–14)
15. Singapore Application No:
11202008796V, filed September 9,
2020, (E–097–2018–0–SG–15)
16. United States of America
Application No: 16/980,205, filed
September 11, 2020 (E–097–2018–
0–US–16)
17. South Africa Application No: 2020/
05571, filed September 8, 2020 (E–
097–2018–0–ZA–17)
The patent rights in these inventions
have been assigned and/or exclusively
licensed to the government of the
United States of America.
The prospective exclusive license
territory may be worldwide, and the
fields of use may be limited to the
following:
An exclusive license to:
1. The development of a CD33specific logic-gated CAR-based
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Page 3163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00653]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Institute of Neurological Disorders and Stroke.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and
evaluation of individual intramural programs and projects conducted by
the NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: April 11-13, 2021.
Time: 3:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lorna W. Role, Ph.D., Scientific Director,
Division of Intramural Research, National Institute of Neurological
Disorders and Stroke, 35A Convent Drive, MSC 3716, Bethesda, MD
20892, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: January 8, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-00653 Filed 1-13-21; 8:45 am]
BILLING CODE 4140-01-P
